Thrombotic microangiopathy and anti-VEGF agents

被引：67

作者：

Izzedine, Hassane ^{[1
]}

Brocheriou, Isabelle

Deray, Gilbert

Rixe, Olivier

机构：

[1] Hop La Pitie Salpetriere, Dept Nephrol, Paris, France

[2] Hop La Pitie Salpetriere, Dept Pathol, Paris, France

[3] Hop La Pitie Salpetriere, Dept Oncol, Paris, France

来源：

NEPHROLOGY DIALYSIS TRANSPLANTATION | 2007年 / 22卷 / 05期

关键词：

D O I：

10.1093/ndt/gfl565

中图分类号：

R3 [基础医学]; R4 [临床医学];

学科分类号：

1001 ; 1002 ; 100602 ;

摘要：

引用

页码：1481 / 1482

页数：3

共 4 条

[1] Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer [J].

Hurwitz, H ;

Fehrenbacher, L ;

Novotny, W ;

Cartwright, T ;

Hainsworth, J ;

Heim, W ;

Berlin, J ;

Baron, A ;

Griffing, S ;

Holmgren, E ;

Ferrara, N ;

Fyfe, G ;

Rogers, B ;

Ross, R ;

Kabbinavar, F .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (23) :2335-2342

[2] Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer [J].

Johnson, DH ;

Fehrenbacher, L ;

Novotny, WF ;

Herbst, RS ;

Nemunaitis, JJ ;

Jablons, DM ;

Langer, CJ ;

DeVore, RF ;

Gaudreault, J ;

Damico, LA ;

Holmgren, E ;

Kabbinavar, F .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (11) :2184-2191

[3] Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria [J].

Sugimoto, H ;

Hamano, Y ;

Charytan, D ;

Cosgrove, D ;

Kieran, M ;

Sudhakar, A ;

Kalluri, R .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (15) :12605-12608

[4] A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer [J].

Yang, JC ;

Haworth, L ;

Sherry, RM ;

Hwu, P ;

Schwartzentruber, DJ ;

Topalian, SL ;

Steinberg, SM ;

Chen, HX ;

Rosenberg, SA .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (05) :427-434

← 1 →